Minneslate Logo

SF2837 (Legislative Session 94 (2025-2026))

Commissioner of corrections maintenance of a supply of opiate antagonists to administer to persons who overdose in correctional facilities requirement; administration of opiate antagonist training to employees requirement

Related bill: HF1399

AI Generated Summary

Purpose of the Bill

This proposed legislation focuses on enhancing safety and response measures in correctional facilities by ensuring the availability of life-saving medication for opioid overdoses.

Main Provisions

  • Supply of Opiate Antagonists: The bill mandates that the commissioner of corrections maintain an adequate supply of opiate antagonists, such as naloxone, in every correctional facility. These medications are critical for reversing the effects of opioid overdoses.
  • Rapid Accessibility: The bill requires that doses of nasal opiate antagonists be stored strategically throughout the facilities, ensuring quick access in case of an overdose.
  • Training: Correctional facility employees will receive training in recognizing the symptoms of an opioid overdose and administering the nasal opiate antagonists. This training will be developed in collaboration with the commissioner of health.

Significant Changes

  • New Requirements: The bill introduces specific requirements for the storage, maintenance, and training associated with opiate antagonists in correctional facilities, which is a new stipulation under the Minnesota Statutes chapter 241.

Relevant Terms

  • Opiate antagonists
  • Naloxone
  • Opioid overdose
  • Correctional facilities
  • Commissioner of corrections
  • Commissioner of health

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 19, 2025SenateFloorActionIntroduction and first reading
March 19, 2025SenateFloorActionReferred toJudiciary and Public Safety
March 23, 2025SenateFloorActionAuthor added

Citations

 
[
  {
    "analysis": {
      "added": [
        "Inclusion of updated opiate antagonist definitions for correctional facilities."
      ],
      "removed": [
        ""
      ],
      "summary": "Refers to the definition of opiate antagonists as specified in section 604A.04.",
      "modified": [
        ""
      ]
    },
    "citation": "604A.04",
    "subdivision": "subdivision 1"
  },
  {
    "analysis": {
      "added": [
        "Clarifies storage and administration regulations."
      ],
      "removed": [
        ""
      ],
      "summary": "Addresses compliance with the storage and administration of opiate antagonists under section 151.37.",
      "modified": [
        ""
      ]
    },
    "citation": "151.37",
    "subdivision": "subdivision 12"
  }
]

Sponsors